The biotech IPO landscape gains momentum in 2025 as Aurion Biotech, Maze Therapeutics, and Metsera file for offerings. Aurion focuses on regenerative therapies, Maze advances precision medicines for ...

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing ...

Stuart continues to advance the development of this new drug class for treatment of multiple indications in ophthalmology," said Eric Schlumpf, President & CEO of Stuart. "We want to express our ...

Oxygen plays a critical role in regulating cell migration and proliferation during wound repair ... other types of tissue injuries could extend its therapeutic potential. In summary, the development ...

Vyznova a human corneal endothelial cell therapy. It is formulated as solution for intracameral route of administration. Vyznova is indicated for the treatment of bullous keratopathy of the cornea. AE ...

Dr. Barriga and colleagues found that cells of the neural crest are directed by internal electric fields during development, much like drivers follow the signals of a traffic warden. The group ...

"Combining these two results therefore shows that there are two mechanisms for endothelial tip cell migration during development in zebrafish. "How endothelial cells migrate is very important ...

According to the company, the implantation demonstrated significant improvements in both distance and near vision, with manageable safety outcomes and minimal impact on corneal endothelium cell ...

SING IMT improved distance and near vision in AMD patients, with minimal impact on corneal endothelial cell density and manageable safety outcomes. At 6 months post-surgery, 97.1% of patients achieved ...

Vaccines that generate high levels of antibodies do not necessarily generate high levels of T cells. Development of vaccines must incorporate the viral components that T cells recognise and react ...